Drug intelligence / Profile preview

diprotin A

Development stage
Unknown
Modality
Small Molecules, Peptides
01

Overview

Diprotin A (isoleucine-proline-isoleucine) is a naturally occurring tripeptide that acts as a competitive inhibitor of dipeptidyl peptidase 4 (DPP-4, also known as CD26). Originally isolated from *Bacillus cereus*, it is widely utilized as a research tool to study the regulation of incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which are crucial for glucose homeostasis. In addition to its role in metabolic research, diprotin A is investigated for its ability to enhance the homing and engraftment of hematopoietic stem cells and progenitor cells by preventing the degradation of stromal cell-derived factor-1 (SDF-1/CXCL12) by DPP-4. It has also been studied in the context of fungal infections, where it is exported in extracellular vesicles by *Cryptococcus* species and modulates fungal physiology and pathogenesis.

Other names
ILE-PRO-ILEIPIisoleucine-proline-isoleucineL-isoleucyl-L-prolyl-L-isoleucine
02

Targets

DPP-4 (Dipeptidyl Peptidase-IV)

Beyond the preview

Go deeper on diprotin A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diprotin A.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call